• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[卫生经济的经济分析类型综述]

[A review of the types of economic analyses of the health economy].

作者信息

Pedersen K M, Alban A, Danneskiold-Samsøe B

机构信息

Vejle Amtskommune, Dansk Sygehus Institut, København.

出版信息

Ugeskr Laeger. 1990 Jan 15;152(3):144-8.

PMID:2105550
Abstract

Great confusion is involved concerning health economics analyses. For example: What is the difference between cost-benefit and cost-effectiveness analyses? Is there a difference between the so-called cost-of-illness analyses? What is a financial analysis? These questions are discussed on the basis of the underlying economic theory and the use of the analyses. In order to avoid terminological confusion, the English terminology is retained. Cost-benefit and cost-effectiveness analyses are social economical analyses because they are all-embracing as regards what is understood by costs and profits based on the so-called welfare economy where cost-benefit analyses are concerned. The theoretical basis for cost-effectiveness analysis is slightly more obscure. Where both forms of analysis are concerned, no concern is shown for who obtains the profits or who pays the costs, i.e. a cross-sectional perspective. The financial analysis contrasts with this because attention is focussed directly on expenditures and revenues and the accounts responsible for the expenses and which obtain the revenues. The cost-of-illness analysis is a confusing but frequently employed and quoted form of analysis where an attempt is made to calculate the costs of a certain disease or injurious agent (alcohol, tobacco, accidents) for the various parties involved. These are subdivided into direct costs, roughly corresponding to the costs of treatment and indirect costs which include e.g. loss of income resulting from the illness, disability or death. This form of analysis is strongly warned against as the results of analysis may easily be misused frequently with absurd implications.

摘要

健康经济学分析存在很大的混淆。例如:成本效益分析和成本效果分析之间有什么区别?所谓的疾病成本分析之间有区别吗?什么是财务分析?这些问题将基于基础经济理论和分析的用途进行讨论。为避免术语混淆,保留英文术语。成本效益分析和成本效果分析属于社会经济分析,因为就基于所谓福利经济中对成本和利润的理解而言,它们涵盖了所有方面,成本效益分析也是如此。成本效果分析的理论基础略显模糊。就这两种分析形式而言,并不关心谁获得利润或谁支付成本,即采用横断面视角。财务分析与此形成对比,因为它直接关注支出和收入以及负责支出和获得收入的账目。疾病成本分析是一种令人困惑但经常使用和引用的分析形式,试图计算某种疾病或有害因素(酒精、烟草、事故)对相关各方造成的成本。这些成本分为直接成本,大致相当于治疗成本,以及间接成本,例如包括因病、残疾或死亡导致的收入损失。强烈警告不要使用这种分析形式,因为分析结果可能很容易被滥用,而且常常会产生荒谬的含义。

相似文献

1
[A review of the types of economic analyses of the health economy].[卫生经济的经济分析类型综述]
Ugeskr Laeger. 1990 Jan 15;152(3):144-8.
2
An economic approach to health care.一种医疗保健的经济学方法。
Best Pract Res Clin Rheumatol. 2004 Apr;18(2):203-18. doi: 10.1016/j.berh.2004.02.001.
3
Panel on cost-effectiveness in health and medicine recommendations: identifying costs.健康与医学成本效益小组建议:确定成本。
J Clin Psychiatry. 1999;60 Suppl 3:54-6; discussion 57-8.
4
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.
5
[Costs and cost analysis].[成本与成本分析]
Ugeskr Laeger. 1990 Jan 29;152(5):298-303.
6
The costs and benefits of enhanced depression care to employers.加强抑郁症护理对雇主的成本与收益。
Arch Gen Psychiatry. 2006 Dec;63(12):1345-53. doi: 10.1001/archpsyc.63.12.1345.
7
Health economics in developing countries.发展中国家的卫生经济学
J Trop Med Hyg. 1989 Aug;92(4):229-41.
8
Cost-effectiveness analysis and policy choices: investing in health systems.成本效益分析与政策选择:对卫生系统的投资
Bull World Health Organ. 1994;72(4):663-74.
9
[What is healthy economy?].[什么是健康的经济?]
Ugeskr Laeger. 1989 Dec 18;151(51):3464-70.
10
Economic evaluation of health services. Concepts and methodology applied to screening programmes.
Rev Epidemiol Sante Publique. 1981;29(1):85-101.